Febrile seizure risk after vaccination in children 6 to 23 months

Pediatrics

Volumn 138, Issue 1, 2016, Pages

  Duffy, Jonathan ^a   Weintraub, Eric ^a   Hambidge, Simon J ^b   Jackson, Lisa A ^c   Kharbanda, Elyse O ^d   Klein, Nicola P ^e   Lee, Grace M ^f   Marcy, S Michael ^e   Nakasato, Cynthia C ^e   Naleway, Allison ^e   Omer, Saad B ^e   Vellozzi, Claudia ^a   DeStefano, Frank ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d HEALTHPARTNERS INSTITUTE   (United States)

^e KAISER PERMANENTE   (United States)

^f HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; CHILD; DRUG POTENTIATION; FEBRILE CONVULSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; UNITED STATES; VACCINATION; VACCINATION REACTION; ADVERSE EFFECTS; INFANT; RISK ASSESSMENT; SEIZURES, FEBRILE;

FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; MALE; RISK ASSESSMENT; SEIZURES, FEBRILE; VACCINATION;

EID: 84976877749     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-0320     Document Type: Article

References (32)

1. Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics. Febrile seizures: Clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatrics. 2008;121(6): 1281-1286
2. Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med. 1976;295(19): 1029-1033
3. Chung B, Wong V. Relationship between five common viruses and febrile seizure in children. Arch Dis Child. 2007;92(7): 589-593
4. Chiu SS, Tse CY, Lau YL, Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics. 2001;108(4). Available at: Http://pediatrics.aappublications.org/content/108/4/e63
5. Barlow WE, Davis RL, Glasser JW, et al; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9): 656-661
6. Klein NP, Fireman B, Yih WK, et al; Vaccine Safety Datalink. Measlesmumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1). Available at: Http://pediatrics.aappublications.org/content/126/1/e1
7. Broder KR, Martin DB, Vellozzi C. In the heat of a signal: Responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States. Vaccine. 2012;30(11): 2032-2034
8. Hambidge SJ, Glanz JM, France EK, et al; Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006;296(16): 1990-1997
9. Armstrong PK, Dowse GK, Effler PV, et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open. 2011;1(1): E000016
10. Tse A, Tseng HF, Greene SK, Vellozzi C, Lee G; VSD Rapid Cycle Analysis Influenza Working Group. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine. 2012;30(11): 2024-2031
11. US Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP). Available at: Www.cdc.gov/vaccines/acip/index.html. Accessed March 17, 2016
12. McNeil MM, Gee J, Weintraub ES, et al. The Vaccine Safety Datalink: Successes and challenges monitoring vaccine safety. Vaccine. 2014;32(42): 5390-5398
13. Shui IM, Shi P, Dutta-Linn MM, et al; Vaccine Safety Datalink Research Team. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine. 2009;27(39): 5307-5312
14. Rowhani-Rahbar A, Klein NP, Dekker CL, et al; Risk Interval Working Group of the Clinical Immunization Safety Assessment Network. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012;31(1): 271-277
15. Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012;41(2): 514-520
16. Altman DG, Bland JM. Interaction revisited: The difference between two estimates. BMJ. 2003;326(7382): 219
17. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7(3): 286-290
18. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53(RR-6): 1-40
19. Kawai AT, Li L, Kulldorff M, et al. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014;23(5): 548-553
20. Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics. 2000;106(5). Available at: Http://pediatrics.aappublications.org/content/106/5/e62
21. Wilson K, Hawken S, Kwong JC, et al. Adverse events following 12 and 18 month vaccinations: A populationbased, self-controlled case series analysis. PLoS One. 2011;6(12): E27897
22. Rockman S, Becher D, Dyson A, et al. Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine. Vaccine. 2014;32(30): 3869-3876
23. Rockman S, Dyson A, Koernig S, et al. Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events. Vaccine. 2014;32(30): 3861-3868
24. Tseng HF, Sy LS, Liu IL, et al. Postlicensure surveillance for prespecified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013;31(22): 2578-2583
25. US Centers for Disease Control and Prevention. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-7): 1-25
26. US Food and Drug Administration. Package Insert -Pentacel. Available at: Www.fda.gov/BiologicsBloodVac cines/Vaccines/ApprovedProducts/ucm172502.htm. Accessed March 17, 2016
27. US Food and Drug Administration. Package Insert -Pediarix. Available at: Www.fda.gov/BiologicsBloodVac cines/Vaccines/ApprovedProducts/ucm146759.htm. Accessed March 17, 2016
28. Stockwell MS, Broder K, LaRussa P, et al. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine. JAMA Pediatr. 2014;168(3): 211-219
29. US Centers for Disease Control and Prevention. Childhood vaccines and febrile seizures. Available at: Www.cdc.gov/vaccinesafety/concerns/febrile-seizures.html. Accessed March 17, 2016
30. Sadleir LG, Scheffer IE. Febrile seizures. BMJ. 2007;334(7588): 307-311
31. National Center for Immunization and Respiratory Diseases. General recommendations on immunization -recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(2): 1-64
32. Strengell T, Uhari M, Tarkka R, et al. Antipyretic agents for preventing recurrences of febrile seizures: Randomized controlled trial. Arch Pediatr Adolesc Med. 2009;163(9): 799-804